Related references
Note: Only part of the references are listed.The role of mutant p53 in human cancer
Amanda M. Goh et al.
JOURNAL OF PATHOLOGY (2011)
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
TP53 Mutations and Pathologic Complete Response to Neoadjuvant Cisplatin and Fluorouracil Chemotherapy in Resected Oral Cavity Squamous Cell Carcinoma
Federica Perrone et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer
Jennifer P. Morton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Mutant p53 Gain-of-Function in Cancer
Moshe Oren et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
TP53 Mutations in Human Cancers: Origins, Consequences, and Clinical Use
Magali Olivier et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
Rapamycin Prevents Early Onset of Tumorigenesis in an Oral-Specific K-ras and p53 Two-Hit Carcinogenesis Model
Ana R. Raimondi et al.
CANCER RESEARCH (2009)
Mutant p53 Drives Invasion by Promoting Integrin Recycling
Patricia A. J. Muller et al.
CELL (2009)
Presence of dominant negative mutation of TP53 is a risk of early recurrence in oral cancer
Nur Mohammad Monsur Hassan et al.
CANCER LETTERS (2008)
TP53 mutations and survival in squamous-cell carcinoma of the head and neck
M. Luana Poeta et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
An inducible mouse model for skin cancer reveals distinct roles for gain- and loss-of-function p53 mutations
Carlos Caulin et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
P53 gain-of-function cancer mutants induce genetic instability by inactivating ATM
Hoseok Song et al.
NATURE CELL BIOLOGY (2007)
The chemoradiation paradigm in head and neck cancer
Tanguy Y. Seiwert et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2007)
Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints
Jirina Bartkova et al.
NATURE (2006)
Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication
Raffaella Di Micco et al.
NATURE (2006)
Gain of function of mutant p53: The mutant p53/NF-Y protein complex reveals an aberrant transcriptional mechanism of cell cycle regulation
Silvia Di Agostino et al.
CANCER CELL (2006)
DNA adducts from acetaldehyde: implications for alcohol-related carcinogenesis
PJ Brooks et al.
ALCOHOL (2005)
Mutation of P53 in head and neck squamous cell carcinoma correlates with BCL-2 expression and increased susceptibility to cisplatin-induced apoptosis
GA Andrews et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2004)
Inducible activation of oncogenic K-ras results in tumor formation in the oral cavity
C Caulin et al.
CANCER RESEARCH (2004)
Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome
GA Lang et al.
CELL (2004)
Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome
KP Olive et al.
CELL (2004)
Chromosome stability, in the absence of apoptosis, is critical for suppression of tumorigenesis in Trp53 mutant mice
G Liu et al.
NATURE GENETICS (2004)
Cyclin B1 promoter activity and functional CDK1 complex formation in G1 phase of human breast cancer cells
KLB Barrett et al.
CELL BIOLOGY INTERNATIONAL (2002)
Medical progress - Head and neck cancer
A Forastiere et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras
EL Jackson et al.
GENES & DEVELOPMENT (2001)
Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer
J Jonkers et al.
NATURE GENETICS (2001)
A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain
C Gaiddon et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)